about
Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymomaPathway analysis of primary central nervous system lymphoma.Role of breast regression protein-39/YKL-40 in asthma and allergic responsesInsights into the biology of primary central nervous system lymphomaThe chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies.Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma.Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients.Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis.Plasma YKL-40: a potential new cancer biomarker?Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients.hYKL-40 cancer biomarker electroanalysis in serum samples and model cell lysates: capacitive immunosensing compared with enzyme label immunosorbent assays (ELISA).Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.Immunohistochemical expression of YKL-40 in peritoneal endometriosis.Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma.Biomarkers in radiation oncology.
P2860
Q24652909-C50FCA96-AB06-43B7-BBCB-A359443AFF3EQ30481424-45D24212-536B-4703-97FD-BBC240844653Q33701312-62336BC0-4B7F-4911-B11A-7E37038D1A81Q33946618-E207399D-9CE4-40E5-8C02-E9CDEB2B9EABQ34031351-42F831E7-08EA-4E41-B4AC-9DBC115C3758Q34494109-12C4D2E5-7FA8-4131-8E3E-157617368DEDQ35152569-2C21B695-C25E-40D5-B822-5FCC19686249Q36545468-64D4230B-2650-4E6C-8E28-2EB002440348Q37273123-0D8F2C3D-CF4B-459D-970F-3F7B00C36AF1Q37334247-3A6CEB9F-9A4F-4851-80C0-88DB56339F03Q37390664-73F74CBA-452A-465A-B84E-156184E3C175Q37486590-558DCE1F-8DF7-4775-A10A-956E12FFC751Q37605869-FECC68C6-1470-4F89-9E55-858159579137Q37706359-E78F9C90-5040-4D9F-A1A6-F46FE0D3528BQ38720400-EB983052-C3B4-4D0A-80D5-D8A4D788FCB6Q38915171-F3DBD37B-A5B0-4EE2-A695-F099398A2330Q42221121-6184ED9B-15E9-43DA-9080-FE89ADF5D287Q43011817-15E64052-6F61-4923-A9F3-BA01027511E2Q45035556-DAE80B71-2AC9-4038-9F50-ECD070F1B4D6Q45235765-169E7F1A-4E49-4F2F-93F0-8E52ABF74923Q47567437-D33F3014-D8A0-4A49-9FF3-6AC4327FB2E6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Is YKL-40 a new therapeutic target in cancer?
@ast
Is YKL-40 a new therapeutic target in cancer?
@en
type
label
Is YKL-40 a new therapeutic target in cancer?
@ast
Is YKL-40 a new therapeutic target in cancer?
@en
prefLabel
Is YKL-40 a new therapeutic target in cancer?
@ast
Is YKL-40 a new therapeutic target in cancer?
@en
P2093
P2860
P1476
Is YKL-40 a new therapeutic target in cancer?
@en
P2093
Anne Roslind
Benny Vittrup Jensen
Julia S Johansen
Paul A Price
P2860
P304
P356
10.1517/14728222.11.2.219
P407
P577
2007-02-01T00:00:00Z